President Trump’s Division of Justice seems to be the company that may evaluation CVS Well being’s $sixty nine billion merger with Aetna, sources inform The Publish.
Whereas the choice isn’t but remaining, the transfer wouldn’t be excellent news for the merging events, sources stated.
“I feel they would like it to be on the Federal Commerce Fee,” one Washington, DC, supply stated.
The Division of Justice is presently suing AT&T to cease its $eighty five billion merger with Time Warner — a case that has some comparable traits to the CVS Well being-Aetna deal.
There’s robust hypothesis from Beltway sources, together with one near the merging events, that the division — not the FTC — is about to get the proper to assessment the deal, although there was no ultimate choice.
The FTC, an unbiased company, sometimes has reviewed drugstore offers, and the Division of Justice, a part of the chief department, has reviewed medical insurance mergers, so each have declare to this assessment.
When the DOJ and FTC each need to evaluation a case, they attempt to attain a compromise.
At present, there are solely two FTC commissioners as an alternative of its traditional 5, which is perhaps making it more durable for the company to foyer for the case, the Washington supply stated.
“Not having a full complement of commissioners is a possible drawback,” the supply famous.
Additionally, the Division of Justice in January gained a go well with stopping Aetna from buying Humana, and experience gained from that case might give it a superb foundation for taking over CVS-Aetna. The division declined to remark.
In the meantime, DOJ legal professionals and their AT&T counterparts will meet on Thursday in courtroom for the primary time.
At a pre-trial listening to, US District Decide Richard Leon is predicted to set the date of what might quantity to one of many extra essential antitrust trials prior to now decade.